Stock Quote

Teva Pharmaceutical Industries Ltd (TEVA.O) (Nasdaq)
As of  1:32pm EST
53.64USD
Price Change
+0.92
Percent Change
+1.75%
 
$53.64
1:32pm EST
+1.75%
$52.72
$53.06
2,266,647
$53.65
$52.97
$54.95
$40.50
0.27
4,385,289

Research Another Stock: Symbol Look-up
Five Fast-Growing Stocks to Buy
5:00am EST(The Street) 
Why a Market Crash Doesn’t Matter
Sunday, 22 Nov 2009 09:36am EST(Seeking Alpha) 
Is Tech Overvalued?
Sunday, 22 Nov 2009 07:49am EST(Seeking Alpha) 
Pfizer's Generic Growth, With a Side of Sashimi
Thursday, 19 Nov 2009 10:03am EST(The Motley Fool) 
American Funds' Achilles' Heel
Tuesday, 17 Nov 2009 10:47am EST(The Motley Fool) 
 
Name Current Position Compensation
Hurvitz, Eli Chairman of the Board --
Yanai, Shlomo Chief Executive Officer, President --
Frost, Phillip Vice Chairman of the Board --

Profile

Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical company that develops, produces and markets generic drugs covering all treatment categories. The Company has a pharmaceutical business, whose principal products are Copaxone for multiple sclerosis and Azilect for Parkinson’s... Full Description

Company Address

Teva Pharmaceutical Industries Ltd
5 Basel Street
PO Box 3190
Petach Tikva     49131
P: +9723.9267267
F: +9723.9267472

Analyst Research

  TEVA.O Industry
P/E(TTM) 57.70 3.57
P/S(TTM) 3.64 0.57
ROI(TTM) 4.18 1.86
ROE(TTM) 5.47 2.51
Consensus Recommendation Outperform
EPS Est. (Current Period) --
EPS Est. (Current Year) 3.15
Total Revenue $13,525.50M
Net Income $2,484.12M
EPS $2.70